NCT06622265View on ClinicalTrials.gov

WHOOP ECG Software Performance Assessment Study

CompletedOBSERVATIONAL
Enrollment

540

Participants

Timeline

Start Date

May 15, 2024

Primary Completion Date

July 3, 2024

Study Completion Date

July 3, 2024

Conditions
Atrial Fibrillation (AF)
Interventions
DEVICE

Electrocardiogram recording

ECG recording with investigational device

Trial Locations (7)

27607

Eximia Research-NC, LLC, Raleigh

32789

Flourish Research, Winter Park

55102

Fairview Frontiers, Saint Paul

66219

IQVIA, Lenexa

85018

HOPE Research Institute, Phoenix

91325

Valley Clinical Trials, Northridge

91723

Valley Clinical Trials, Covina

All Listed Sponsors
lead

Whoop Inc.

INDUSTRY

NCT06622265 - WHOOP ECG Software Performance Assessment Study | Biotech Hunter | Biotech Hunter